More than 40 years and 1,000 or so patents after selling his first company, AutoSyringe, to healthcare giant Baxter, Dean Kamen still gets a charge describing breakthrough innovation. It’s been five years since his organ fabricating project ARMI (Advanced Regenerative Manufacturing Institute) divided critics.
The project made more waves early last month, at the CNN-hosted conference Life Itself. Kamen paints the picture appearing on a panel at TC Sessions: Robotics today:
Doris Taylor, who moved up here from where she spent more than a decade in Texas, at the Texas Heart Institute, she g
コメント